Imaging of Myocardial Fibrosis in Patients with End-Stage Renal Disease: Current Limitations and Future Possibilities

Cardiovascular disease in patients with end-stage renal disease (ESRD) is driven by a different set of processes than in the general population. These processes lead to pathological changes in cardiac structure and function that include the development of left ventricular hypertrophy and left ventri...

Descripción completa

Detalles Bibliográficos
Autores principales: Graham-Brown, M. P. M., Patel, A. S., Stensel, D. J., March, D. S., Marsh, A.-M., McAdam, J., McCann, G. P., Burton, J. O.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2017
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5352874/
https://www.ncbi.nlm.nih.gov/pubmed/28349062
http://dx.doi.org/10.1155/2017/5453606

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5352874/
https://www.ncbi.nlm.nih.gov/pubmed/28349062
http://dx.doi.org/10.1155/2017/5453606

Ejemplares similares